2A4R | Viral Protein | date | Jun 29, 2005 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Hcv Ns3 Protease Domain With A Ketoamide Inhibitor Covalentl | ||||||||||||||
authors | S.Bogen, A.K.Saksena, A.Arasappan, H.Gu, F.G.Njoroge, V.Girijaval J.Pichardo, N.Butkiewicz, A.Prongay, V.Madison | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Ns3 Proteasehelicase Chain: A, C Fragment: Protease Domain, Residues 1-181 Engineered: Yes |
Organism_scientific: Hepatitis C Virus Organism_taxid: 11103 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
Molecule: Ns4a Peptide Chain: B, D Fragment: Residues 21-39 Engineered: Yes |
Synthetic: Yes Other_details: The Peptide Was Chemically Synthesized. The Of The Protein Is Naturally Found In Hepatitis C Virus Type | ||||||||||||||
symmetry | Space Group: H 3 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.40 Å | ||||||||||||
ligand | BNH, ZN BindingDB | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2-P1 cyclopropyl alanine combination for improved potency., Bogen S, Saksena AK, Arasappan A, Gu H, Njoroge FG, Girijavallabhan V, Pichardo J, Butkiewicz N, Prongay A, Madison V, Bioorg Med Chem Lett. 2005 Oct 15;15(20):4515-9. PMID:16112862 |
Data retrieval |
View 2A4R in 3D |
Visual 3D analysis of 2A4R |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2A4R |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |